DeepCurrents Investment Group »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $8.8M 7.8M 1.14
2025-03-31 $13M 10M 1.28
2024-12-31 $15M 14M 1.08
2024-09-30 $16M 14M 1.19

More positions owned by DeepCurrents Investment Group

At&t Put Option (T)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Nova Note 10/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Stride Note 1.125% 9/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Spotify Usa Note 3/1 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Shift4 Pmts Note 12/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Cloudflare Note 8/1 (Principal)
Novocure Note 11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1